These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1710381)

  • 1. Antibody-dependent cellular cytotoxicity (ADCC) in antimyelin antibody-induced oligodendrocyte damage in vitro.
    Griot-Wenk M; Griot C; Pfister H; Vandevelde M
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):122-3. PubMed ID: 1710381
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity in antimyelin antibody-induced oligodendrocyte damage in vitro.
    Griot-Wenk M; Griot C; Pfister H; Vandevelde M
    J Neuroimmunol; 1991 Aug; 33(2):145-55. PubMed ID: 2066397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.
    Scolding NJ; Morgan BP; Houston A; Campbell AK; Linington C; Compston DA
    J Neurol Sci; 1989 Feb; 89(2-3):289-300. PubMed ID: 2926453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oligodendroglia in patients with multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
    N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.
    Schirmer L; Srivastava R; Hemmer B
    Mult Scler; 2014 Mar; 20(3):271-9. PubMed ID: 24589684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)].
    Taranova NP; Kirchik OS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1863-72. PubMed ID: 3911691
    [No Abstract]   [Full Text] [Related]  

  • 7. Demyelination in brain cell aggregate cultures, induced by a monoclonal antibody against the myelin/oligodendrocyte glycoprotein (MOG).
    Honegger P; Matthieu JM; Lassmann H
    Schweiz Arch Neurol Psychiatr (1985); 1989; 140(1):10-3. PubMed ID: 2467359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of multiple sclerosis: status of research].
    Hartung HP
    Wien Med Wochenschr; 1996; 146(19-20):520-7. PubMed ID: 9082652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bystander demyelination through antibody induced macrophage activation in canine distemper virus infection.
    Griot C; Bürge T; Vandevelde M; Peterhans E
    Schweiz Arch Neurol Psychiatr (1985); 1989; 140(1):39-41. PubMed ID: 2467368
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of antimyelin and antioligodendrocyte antibodies by vaccinia virus. An experimental study in the mouse.
    Steck AJ; Tschannen R; Schaefer R
    J Neuroimmunol; 1981 Mar; 1(1):117-24. PubMed ID: 7328173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new oligodendrocyte specific plasma membrane surface protein identified by a monoclonal antibody produced in vitro.
    Birling MC; Nussbaum F; Nussbaum JL
    J Neurosci Res; 1994 Aug; 38(5):538-50. PubMed ID: 7815472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN; Snyder DS
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remembering MOG: autoantibody mediated demyelination in multiple sclerosis?
    Wekerle H
    Nat Med; 1999 Feb; 5(2):153-4. PubMed ID: 9930860
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma.
    Rosenbluth J; Schiff R; Liang WL; Dou W
    J Neurocytol; 2003 Mar; 32(3):265-76. PubMed ID: 14724389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.
    Schluesener HJ; Sobel RA; Linington C; Weiner HL
    J Immunol; 1987 Dec; 139(12):4016-21. PubMed ID: 3500978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid.
    Bansal R; Gard AL; Pfeiffer SE
    J Neurosci Res; 1988; 21(2-4):260-7. PubMed ID: 2464078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiology of oligodendrocytes in multiple sclerosis.
    Ruffini F; Chojnacki A; Weiss S; Antel JP
    Adv Neurol; 2006; 98():47-63. PubMed ID: 16400826
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological studies in demyelinating encephalitis associated with vaccinia virus and canine distemper virus infection.
    Steck AJ; Vandevelde M
    Prog Brain Res; 1983; 59():275-9. PubMed ID: 6198680
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S
    Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiments on the induction of antibody dependent macrophage-mediated cellular cytotoxicity in mixed brain cell cultures.
    Korn J
    Acta Anat (Basel); 1992; 145(4):307-20. PubMed ID: 10457770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.